Pharmacovigilance Strategies for Geriatric Clinical Trials
Pharmacovigilance Strategies for Geriatric Clinical Trials Building Pharmacovigilance That Truly Fits Geriatric Clinical Trials Why Pharmacovigilance Must Be Different for Older Adults Pharmacovigilance (PV) in geriatric trials cannot be a copy‑paste of general adult methods. Aging changes the baseline risk profile—renal and hepatic reserve decline, autonomic responses blunt, and homeostatic buffers narrow. Add multimorbidity and…
Read More “Pharmacovigilance Strategies for Geriatric Clinical Trials” »